Novo Nordisk A/S

CPSE:NOVO B Voorraadrapport

Marktkapitalisatie: DKK 3.2t

Novo Nordisk Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Novo Nordisk heeft een totaal eigen vermogen van DKK120.5B en een totale schuld van DKK57.0B, wat de schuld-eigenvermogensverhouding op 47.3% brengt. De totale activa en totale passiva bedragen respectievelijk DKK397.4B en DKK276.9B. De EBIT Novo Nordisk is DKK119.8B waardoor de rentedekking -262.7 is. Het heeft contanten en kortetermijnbeleggingen van DKK74.9B.

Belangrijke informatie

47.3%

Verhouding schuld/eigen vermogen

DKK 56.97b

Schuld

Rente dekkingsratio-262.7x
ContantDKK 74.88b
AandelenDKK 120.52b
Totaal verplichtingenDKK 276.92b
Totaal activaDKK 397.44b

Recente financiële gezondheidsupdates

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Jul 27
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Apr 14
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Dec 12
Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Recent updates

Solid Earnings May Not Tell The Whole Story For Novo Nordisk (CPH:NOVO B)

Nov 13
Solid Earnings May Not Tell The Whole Story For Novo Nordisk (CPH:NOVO B)

Novo Nordisk A/S (CPH:NOVO B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Nov 09
Novo Nordisk A/S (CPH:NOVO B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Is Novo Nordisk A/S (CPH:NOVO B) Trading At A 31% Discount?

Nov 01
Is Novo Nordisk A/S (CPH:NOVO B) Trading At A 31% Discount?

Novo Nordisk A/S' (CPH:NOVO B) P/E Still Appears To Be Reasonable

Oct 09
Novo Nordisk A/S' (CPH:NOVO B) P/E Still Appears To Be Reasonable

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Jul 27
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Should You Be Adding Novo Nordisk (CPH:NOVO B) To Your Watchlist Today?

Jul 05
Should You Be Adding Novo Nordisk (CPH:NOVO B) To Your Watchlist Today?

A Look At The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

Jun 09
A Look At The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

Novo Nordisk's (CPH:NOVO B) Promising Earnings May Rest On Soft Foundations

May 09
Novo Nordisk's (CPH:NOVO B) Promising Earnings May Rest On Soft Foundations

Results: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts

May 04
Results: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts

The Price Is Right For Novo Nordisk A/S (CPH:NOVO B)

Apr 28
The Price Is Right For Novo Nordisk A/S (CPH:NOVO B)

Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Apr 14
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Mar 18
Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Dec 30
Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Dec 12
Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Nov 24
Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( DKK195.2B ) van NOVO B } dekken niet de korte termijn passiva ( DKK208.4B ).

Langlopende schulden: De kortetermijnactiva NOVO B ( DKK195.2B ) overtreffen de langetermijnschulden ( DKK68.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: NOVO B heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van NOVO B is de afgelopen 5 jaar gestegen van 8.2% naar 47.3%.

Schuldendekking: De schuld van NOVO B wordt goed gedekt door de operationele kasstroom ( 207.5% ).

Rentedekking: NOVO B verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y